跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
34-f
首页
药物
34-f
34-f
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
A MODIFIED PROTEIN SCAFFOLD AND USE THEREOF
US 20260098080 A1
申请人: EVOLVERITAS BIOTECHNOLOGIAI KORLATOLT FELELOSSEGU TARSASAG
优先权: 2022
CN
EP
US
WO
4 件公开
PTH mimetic peptide based on protein domain reconstruction and application thereof
US 11912752 B2
申请人: YANG DEHONG
优先权: 2018
CN
US
2 件公开
Anti-rabbit CD19 antibodies and methods of use
US 12378315 B2
申请人: HOFFMANN LA ROCHE
优先权: 2018
CN
US
2 件公开
Fluorescent proteins
US 7335488 B2
申请人: UNIV HONG KONG CHINESE
优先权: 2003
US
Solid water-in-oil emulsion make-up composition
US 2005191329 A1
申请人: TANIGUCHI TOSHIYA
优先权: 2005
US
PRODUCTION AND USE OF ZINC AMIDES
US 2011288296 A1
申请人: KNOCHEL PAUL
优先权: 2009
US
Method for Assessing Myelodysplastic Syndrome or Myeloid Tumor Predisposition, Polypeptide and Antibody Therefor, and Candidate Screening Method for Therapeutic Drug or Prophylactic Drug Therefor
US 2014303020 A1
申请人: OGAWA SEISHI
优先权: 2011
US
Diploid cell adaptive method of F genotype mumps viral strain MHM-19
CN 103756976 A
申请人: BEIJING MINHAI BIOTECHNOLOGY CO LTD
优先权: 2014
CN
Compounds and formulations for reducing scarring
EP 3020398 A1
申请人: NITTO DENKO CORP
优先权: 2014
EP
Medicament capable of treating lung cancer by virtue of combined treatment of traditional Chinese medicine and western medicine
CN 105687450 A
申请人: AFFILIATED HOSPITAL QINGDAO UNIV
优先权: 2016
CN
第 1 / 2 页
上一页
下一页
药物
反馈